This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2003 Nov;80(5):1121-2.

doi: 10.1016/s0015-0282(03)02190-3.

Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles

Madelon van Wely¹, Lars G Westergaard, Patrick M M Bossuyt, Fulco van der Veen

Affiliations

PMID: 14607560
DOI: 10.1016/s0015-0282(03)02190-3

Free article

Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles

Madelon van Wely et al. Fertil Steril. 2003 Nov.

Free article

. 2003 Nov;80(5):1121-2.

doi: 10.1016/s0015-0282(03)02190-3.

Authors

Madelon van Wely¹, Lars G Westergaard, Patrick M M Bossuyt, Fulco van der Veen

Affiliation

¹ Academic Medical Center, Amsterdam, The Netherlands. m.vanwely@amc.uva.nl

PMID: 14607560
DOI: 10.1016/s0015-0282(03)02190-3

No abstract available

PubMed Disclaimer

Similar articles

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
van Wely M, Westergaard LG, Bossuyt PM, van der Veen F. van Wely M, et al. Fertil Steril. 2003 Nov;80(5):1086-93. doi: 10.1016/s0015-0282(03)02187-3. Fertil Steril. 2003. PMID: 14607553
Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies.
Kelly E. Kelly E. Fertil Steril. 2003 Nov;80(5):1105-7. doi: 10.1016/s0015-0282(03)02186-1. Fertil Steril. 2003. PMID: 14607556 Review. No abstract available.
A turbulent arena.
Collins J. Collins J. Fertil Steril. 2003 Nov;80(5):1117-20. doi: 10.1016/s0015-0282(03)02191-5. Fertil Steril. 2003. PMID: 14607559 No abstract available.
Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction.
Daya S. Daya S. Fertil Steril. 2003 Nov;80(5):1100-4. doi: 10.1016/s0015-0282(03)02193-9. Fertil Steril. 2003. PMID: 14607555 No abstract available.
Clinical efficacy of highly purified hMG versus recombinant FSH in IVF/ICSI cycles: a meta-analysis.
Jee BC, Suh CS, Kim YB, Kim SH, Moon SY. Jee BC, et al. Gynecol Obstet Invest. 2010;70(2):132-7. doi: 10.1159/000308458. Epub 2010 Apr 10. Gynecol Obstet Invest. 2010. PMID: 20389096 Review.

See all similar articles

Cited by

In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review.
Trew GH, Brown AP, Gillard S, Blackmore S, Clewlow C, O'Donohoe P, Wasiak R. Trew GH, et al. Reprod Biol Endocrinol. 2010 Nov 8;8:137. doi: 10.1186/1477-7827-8-137. Reprod Biol Endocrinol. 2010. PMID: 21059191 Free PMC article.
Comparison of ovulation induction and pregnacy outcomes in IVF patients with normal ovarian reserve who underwent long protocol with recombinant-FSH and highly purified-hMG.
Celik C, Sofuoğlu K, Selçuk S, Asoğlu MR, Abalı R, Cetingöz E, Baykal B, Uludoğan M. Celik C, et al. J Turk Ger Gynecol Assoc. 2011 Mar 1;12(1):15-20. doi: 10.5152/jtgga.2011.04. eCollection 2011. J Turk Ger Gynecol Assoc. 2011. PMID: 24591951 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information